PET-CT-guided characterisation of progressive, preclinical tuberculosis infection and its association with low-level circulating Mycobacterium tuberculosis DNA in household contacts in Leicester, UK: a prospective cohort study.
PET-CT-guided characterisation of progressive, preclinical tuberculosis infection and its association with low-level circulating Mycobacterium tuberculosis DNA in household contacts in Leicester, UK: a prospective cohort study.
复制标题
PET-CT 引导下的进展性临床前结核感染特征及其与英国莱斯特家庭接触者中低水平循环结核分枝杆菌 DNA 的关联:一项前瞻性队列研究。
DOI:
10.1016/s2666-5247(23)00289-6
复制
发表时间:
2024
期刊:
影响因子:
--
通讯作者:
Kim JW
中科院分区:
文献类型:
--
作者:
Kim JW
BackgroundIncipient tuberculosis, a progressive state ofMycobacterium tuberculosisinfection with an increased risk of developing into tuberculosis disease, remains poorly characterised. Animal models suggest an association of progressive infection with bacteraemia. CirculatingM tuberculosisDNA has previously been detected in pulmonary tuberculosis by use of Actiphage, a bacteriophage-based real-time PCR assay. We aimed to investigate whether serial [18F]fluorodeoxyglucose ([18F]FDG)-PET-CT could be used to characterise the state and progressive trajectory of incipient tuberculosis, and examine whether these PET-CT findings are associated with Actiphage-based detection of circulatingM tuberculosisDNA.MethodsWe did a prospective 12-month cohort study in healthy, asymptomatic adults (aged ≥16 years) who were household contacts of patients with pulmonary tuberculosis, and who had a clinical phenotype of latent tuberculosis infection, in Leicester, UK. Actiphage testing of participants' blood samples was done at baseline, and [18F]FDG PET-CT at baseline and after 3 months. Baseline PET-CT features were classified as positive, indeterminate, or negative, on the basis of the quantitation (maximum standardised uptake value [SUVmax]) and distribution of [18F]FDG uptake. Microbiological sampling was done at amenable sites of [18F]FDG uptake. Changes in [18F]FDG uptake after 3 months were quantitatively categorised as progressive, stable, or resolving. Participants received treatment if features of incipient tuberculosis, defined as microbiological detection ofM tuberculosisor progressive PET-CT change, were identified.Findings20 contacts were recruited between Aug 5 and Nov 5, 2020; 16 of these participants had a positive result on IFNγ release assay (QuantiFERON-TB Gold Plus [QFT]) indicating tuberculosis infection. Baseline PET-CT scans were positive in ten contacts (all QFT positive), indeterminate in six contacts (three QFT positive), and negative in four contacts (three QFT positive). Four of eight PET-CT-positive contacts sampled hadM tuberculosisidentified (three through culture, one through Xpert MTB/RIF Ultra test) from intrathoracic lymph nodes or bronchial wash and received full antituberculosis treatment. Two further unsampled PET-CT-positive contacts were also treated: one with [18F]FDG uptake in the lung (SUVmax9·4) received empirical antituberculosis treatment and one who showed progressive [18F]FDG uptake received preventive treatment. The ten untreated contacts with [18F]FDG uptake at baseline (seven QFT positive) had stable or resolving changes at follow-up and remained free of tuberculosis disease after 12 months. A positive baseline Actiphage test was associated with the presence of features of incipient tuberculosis requiring treatment (p=0·018).InterpretationMicrobiological and inflammatory features of incipient tuberculosis can be visualised on PET-CT and are associated withM tuberculosisdetection in the blood, supporting the development of pathogen-directed blood biomarkers of tuberculosis risk.FundingMRC Confidence in Concept.
登录
查看更多内容
影响因子:
82.9
作者:
Esmail, Hanif;Lai, Rachel P.;Lesosky, Maia;Wilkinson, Katalin A.;Graham, Christine M.;Coussens, Anna K.;Oni, Tolu;Warwick, James M.;Said-Hartley, Qonita;Koegelenberg, Coenraad F.;Walzl, Gerhard;Flynn, JoAnne L.;Young, Douglas B.;Barry, Clifton E., III;O'Garra, Anne;Wilkinson, Robert J.
通讯作者:
Wilkinson, Robert J.
影响因子:
4.6
作者:
Yuanyuan Ji;C. Shao;Yong;Guangrui Shao;Jingsong Zheng
通讯作者:
Jingsong Zheng
DOI:
10.1016/s1473-3099(17)30488-7
发表时间:
2017-12
期刊:
The Lancet. Infectious diseases
影响因子:
--
作者:
Yoon C;Semitala FC;Atuhumuza E;Katende J;Mwebe S;Asege L;Armstrong DT;Andama AO;Dowdy DW;Davis JL;Huang L;Kamya M;Cattamanchi A
通讯作者:
Cattamanchi A
影响因子:
3.7
作者:
Tornack J;Reece ST;Bauer WM;Vogelzang A;Bandermann S;Zedler U;Stingl G;Kaufmann SH;Melchers F
通讯作者:
Melchers F